All the content of the library is provided from Mayo Clinic in English.
As a member of the Mayo Clinic Care Network, RSPP has special access to Mayo Clinic knowledge and resources.
Acute myelogenous leukemia, also called AML, is a cancer of the blood and bone marrow. Bone marrow is the soft matter inside bones where blood cells are made.
The word "acute" in acute myelogenous leukemia means the disease tends to get worse quickly. It's called myelogenous (my-uh-LOHJ-uh-nus) leukemia because it affects cells called the myeloid cells. These typically develop into mature blood cells, including red blood cells, white blood cells and platelets.
AML is the most common type of acute leukemia in adults. The other type is acute lymphoblastic leukemia, also called ALL. Although AML can be diagnosed at any age, it is less common before age 45. AML also is called acute myeloid leukemia, acute myeloblastic leukemia, acute granulocytic leukemia and acute nonlymphocytic leukemia.
Unlike other cancers, there are no numbered stages of acute myelogenous leukemia.
Symptoms of acute myelogenous leukemia may include:
Make an appointment with your healthcare professional if you have ongoing symptoms that worry you. Acute myelogenous leukemia symptoms are like those of many more-common conditions, such as infections. The healthcare professional may check for those causes first.
It's often not clear what causes acute myelogenous leukemia.
Healthcare professionals know that it starts when something causes changes to the DNA inside cells in the bone marrow. The bone marrow is the spongy material inside bones. It's where blood cells are made.
The changes that lead to acute myelogenous leukemia are thought to happen in cells called myeloid cells. Myeloid cells are bone marrow cells that can turn into the blood cells that circulate through the body. Healthy myeloid cells can become:
Every cell in the body contains DNA. A cell's DNA holds the instructions that tell the cell what to do. In healthy cells, the DNA gives instructions to grow and multiply at a set rate. The instructions tell the cells to die at a set time. But when the DNA changes happen in the myeloid cells, the changes give different instructions. The myeloid cells start to make a lot of extra cells, and they don't stop.
The DNA changes cause the myeloid cells to make a lot of immature white blood cells, called myeloblasts. The myeloblasts don't work right. They can build up in the bone marrow. They can crowd out healthy blood cells. Without enough healthy blood cells, there might be low oxygen levels in the blood, easy bruising and bleeding, and frequent infections.
Factors that may increase the risk of acute myelogenous leukemia, also called AML, include:
Many people with AML have no known risk factors, and many people who have risk factors never develop the cancer.
Acute myeloid leukemia diagnosis often begins with an exam that checks for bruising, bleeding in the mouth or gums, infection, and swollen lymph nodes. Other tests include blood and lab tests, bone marrow biopsy, lumbar puncture, and imaging.
Tests and exams to diagnose acute myelogenous leukemia, also called AML, include:
Blood tests for acute myelogenous leukemia might include a test to count the number of blood cells in a sample of blood. This test is called a complete blood count. The results may show too many or too few white blood cells. Often the test finds that there are not enough red blood cells and not enough platelets. Another blood test looks for immature white blood cells called myeloblasts in the blood. These cells typically aren't found in the blood. But they can occur in the blood of people with AML.
Bone marrow aspiration and biopsy are procedures that involve collecting cells from the bone marrow. In bone marrow aspiration, a needle is used to draw a sample of the bone marrow fluid. In a bone marrow biopsy, a needle is used to collect a small amount of solid tissue. The samples are typically taken from the hip bone. The samples go to a lab for testing.
In the lab, tests can look for DNA changes in the bone marrow cells. Which DNA changes are present in your bone marrow cells are an important part of diagnosing AML. The results can help your healthcare team create a treatment plan.
Sometimes, a lumbar puncture may be needed if there's concern that the leukemia has spread to the brain and spinal cord. A lumbar puncture also is called a spinal tap. It removes a sample of the fluid that surrounds the brain and spinal cord. A small needle is inserted into the lower back to remove a fluid sample. The sample is sent to a lab.
Imaging tests make pictures of the body. For AML, imaging tests might make pictures of the brain, if there's concern that the leukemia cells have spread there. Imaging might include CT or MRI. If there's concern that the leukemia might have spread to another part of the body, imaging might be done with a positron emission tomography scan, also called a PET scan.
If you're diagnosed with AML, you may need further lab tests to determine your AML subtype. These tests include examining your blood and bone marrow for genetic changes and other signs that indicate specific AML subtypes. Currently, there are 15 different subtypes. Your AML subtype helps your healthcare professional determine the best treatment for you.
Many types of treatment exist for acute myelogenous leukemia, also called AML. Treatment depends on several factors, including the subtype of the disease, your age, your overall health, your prognosis and your preferences.
Treatment usually has two phases:
Treatments include:
Chemotherapy. Chemotherapy treats cancer with strong medicines. Most chemotherapy medicines are given through a vein. Some come in pill form. Chemotherapy is the main type of remission induction therapy. It also may be used for consolidation therapy.
People with AML usually stay in the hospital during chemotherapy treatments because the medicines kill many healthy blood cells while destroying leukemia cells. If the first chemotherapy cycle doesn't cause remission, it can be repeated.
Side effects of chemotherapy depend on the medicines you're given. Common side effects are nausea and hair loss. Serious, long-term complications may include heart disease, lung damage, fertility problems and other cancers.
Targeted therapy. Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. By blocking these chemicals, targeted treatments can cause cancer cells to die. Your leukemia cells will be tested to see if targeted therapy may be helpful for you. Targeted therapy may be used alone or in combination with chemotherapy during induction therapy.
Bone marrow transplant. A bone marrow transplant, also called a bone marrow stem cell transplant, involves putting healthy bone marrow stem cells into the body. These cells replace cells hurt by chemotherapy and other treatments. A bone marrow stem cell transplant may be used for both remission induction and consolidation therapy.
Before a bone marrow transplant, you receive very high doses of chemotherapy or radiation therapy to destroy your leukemia-producing bone marrow. Then you receive infusions of stem cells from a compatible donor. This is called an allogeneic transplant.
There is an increased risk of infection after a transplant.
Clinical trials. Some people with leukemia choose to enroll in clinical trials to try experimental treatments or new combinations of known therapies.
No alternative treatments have been found to treat acute myelogenous leukemia. But integrative medicine may help you cope with the stress of a cancer diagnosis and side effects of your treatment.
Alternative treatments that may help relieve symptoms include:
Acute myelogenous leukemia is a fast-growing cancer that requires quick decision-making. The following tips and resources may help you cope:
Learn enough about acute myelogenous leukemia to make decisions about your care. The term leukemia can be confusing because it refers to a group of cancers that aren't all that alike except that they all affect the bone marrow and blood.
You can waste a lot of time researching information that doesn't apply to your kind of leukemia. To avoid that, ask your doctor to write down as many details as possible about your specific disease. Then narrow your search to that disease.
Look for information at your local library and on the internet. You can start your information search with the National Cancer Institute and the Leukemia & Lymphoma Society.
Make an appointment with your healthcare professional if you have symptoms that worry you. You may be referred to a doctor who specializes in blood cell diseases. This type of doctor is called a hematologist.
Appointments can be brief, and there's a lot of information to discuss. It's a good idea to be prepared. Here's some information to help you get ready:
Your time with your healthcare professional is limited, so preparing a list of questions can help make the most of your time together. List your questions from most to least important in case time runs out. For acute myelogenous leukemia, some basic questions to ask include:
In addition to the questions that you've prepared, don't hesitate to ask other questions.
Your healthcare professional is likely to ask you questions. Being ready to answer them may give you more time to go over other questions you have. Questions may include:
Avoid activities that worsen your symptoms. For instance, try to take it easy if you're feeling very tired.